Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Anamorelin structure

Anamorelin

Growth Hormone
Phase 3 Research
70%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 100 mg
Range 100 - 100 mg
Maintenance 100 mg daily

Pharmacokinetics

Half-Life 8.0 hrs
Onset 45 min
Peak 2.0 hrs
Duration 12.0 hrs
Bioavailability 65%
Primary Route Oral

Administration

Routes Oral
Syringe Type Oral
Timing Morning, Fasted

Special Instructions

Take on empty stomach 1 hour before first meal. Approved in Japan for cancer cachexia. CYP3A4 interactions possible.